Corona Treatment: Blood Thinner Drugs Can Save Covid-19 PatientsKOMPAS.com - Since the new corona virus broke out in China, until now no medicine or vaccine has been found.However, up to nearly 4 million people were infected, more than 1.3 million people recovered from the disease.Doctors and medical personnel around the world provide a variety of treatments.As reported by Science Daily, Friday (8/5/2020), to treat Covid-19 patients who have blood clots, doctors at Mount Sinai Hospital use blood thinners.Mount Sinai Hospital is the sixth hospital in the United States specializing in cardiology and cardiac surgery.Also read: This Corona Virus Infection Effect Confuses Doctors, How Can You?Researchers at the Mount Sinai Covid Informatics Center report that treating Covid-19 patients with anticoagulant drugs or blood thinners can slow blood clotting.This treatment is claimed to increase the chances of survival of patients infected with the SARS-CoV-2 virus.The research was published in the Journal of the American College of Cardiology on May 6 and is considered to provide new insights into how to treat coronavirus patients in hospitals.In this study, it was found that Covid-19 patients who were treated with blood thinners showed an improvement in their health conditions that were getting better while in the intensive care unit.Also read: Researchers Test Recovered Patients' Blood for Covid-19 TreatmentThis research shows that anticoagulants taken by mouth, subcutaneously or intravenously can play a major role in treating Covid-19 patients."This can prevent the possible lethal effects of the coronavirus, such as heart attack, stroke and pulmonary embolism," explains senior author Valentin Fuster, MD, PhD, Mount Sinai Cardiac Director.However, the use of anticoagulants should be considered when a patient is admitted to the ED and has tested positive for Covid-19 to improve outcomes."However, each case must be evaluated individually to account for the potential risk of bleeding."The publication of this study follows recent research from the Icahn School of Medicine at Mount Sinai that showed a number of hospitalized Covid-19 patients exhibited life-threatening blood clots.A team of researchers evaluated the records of 2,773 confirmed COVID-19 positive patients admitted to five hospitals at the Mount Sinai Health System in New York City, between March 14 and April 11, 2020.The focus of this study is on the survival of patients taking blood thinners compared to other patients not receiving these treatments.Also read: CT Scan of this Covid-19 Patient Shows the Severity of the Corona VirusOf the Covid-19 patients analyzed, a total of 786 patients, or about 28 percent, received the full dose of anticoagulants that are usually given to prevent blood clots or are suspected of having blood clots.Among the patients who did not survive, those on anticoagulants died after spending an average of 21 days in the hospital.Shutterstock/Kobkit Chamchod Illustration of corona patient, corona virus, Covid-19Also read: SARS-CoV-2 Corona Genome Sequencing, These are the Benefits for IndonesiaCompared with non-anticoagulated patients who died after a median of 14 days in hospital.The anticoagulant effect has a more pronounced effect in patients on ventilators.A total of 62.7 percent of intubated patients who were not treated with anticoagulants died, whereas 29.1 percent of intubated patients treated with anticoagulants survived.Of the intubated patients who did not survive, those without anticoagulants died after 9 days, whereas those on anticoagulants died after 21 days.All patients in the study underwent blood tests when they arrived at the hospital, which included measuring various inflammatory markers.Read also: Covid-19 study: Corona virus is more susceptible to infection in men and obesityAnalysis showed that patients who received anticoagulants had higher inflammatory markers compared to patients who were not treated with anticoagulants.Furthermore, the results of these tests may advise patients with more severe disease to benefit from anticoagulation early on."We hope that this reported association of anticoagulation therapy with better survival will be confirmed in future investigations," explained the investigators.Scientists at Mount Sinai continue to analyze data on Covid-19 patients to contribute to finding the right treatment for patients infected with the coronavirus.Write your comments with the hashtag #JernihBerkomentar and win e-vouchers for 90 winners!Get information and insight selected by Kompas.com editorsDouble check and complete your data.Your data will be used for account verification when you need assistance or when unusual activity is found on your account.Immediately complete your data to join the #JernihBerkomentar program.